Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
about
Arachidonate 15-lipoxygenase type B knockdown leads to reduced lipid accumulation and inflammation in atherosclerosisω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary RelevanceMIF and CXCL12 in Cardiovascular Diseases: Functional Differences and SimilaritiesChemokines and their receptors in AtherosclerosisACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's diseaseMacrophage function in atherosclerosis: potential roles of TRP channelsPreclinical and Clinical Studies on Antioxidative, Antihypertensive and Cardioprotective Effect of Marine Proteins and Peptides-A ReviewCardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths?Plasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.Anti-Inflammatory Effects of the Mediterranean Diet in the Early and Late Stages of Atheroma Plaque Development.The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice.The influence of ezetimibe on classical and alternative activation pathways of monocytes/macrophages isolated from patients with hypercholesterolemia.Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophagesEffects and mechanisms of indol-2,3-dione on atherosclerosisGene expression during the generation and activation of mouse neutrophils: implication of novel functional and regulatory pathways.Manipulation of the mononuclear phagocyte system by Mycobacterium tuberculosis.Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin.Deletion of CGI-58 or adipose triglyceride lipase differently affects macrophage function and atherosclerosis.Differential regulation of macropinocytosis in macrophages by cytokines: implications for foam cell formation and atherosclerosis.Regulation of ADAMTS-1, -4 and -5 expression in human macrophages: differential regulation by key cytokines implicated in atherosclerosis and novel synergism between TL1A and IL-17.The anti-atherogenic cytokine interleukin-33 inhibits the expression of a disintegrin and metalloproteinase with thrombospondin motifs-1, -4 and -5 in human macrophages: Requirement of extracellular signal-regulated kinase, c-Jun N-terminal kinase aIRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisArachidonate 15-lipoxygenase enzyme products increase platelet aggregation and thrombin generationSaponins of Panax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases.The phosphoinositide 3-kinase signaling pathway is involved in the control of modified low-density lipoprotein uptake by human macrophagesProtein Kinase C Is Involved in the Induction of ATP-Binding Cassette Transporter A1 Expression by Liver X Receptor/Retinoid X Receptor Agonist in Human Macrophages.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.Foam Cell Formation In Vivo Converts Macrophages to a Pro-Fibrotic PhenotypeFoam cells and the pathogenesis of kidney disease.A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro.Apple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE-/- Mice through the ROS/MAPK/NF-κB PathwayCytokines: roles in atherosclerosis disease progression and potential therapeutic targetsNutraceutical therapies for atherosclerosis.The role of mitogen-activated protein kinases and sterol receptor coactivator-1 in TGF-β-regulated expression of genes implicated in macrophage cholesterol uptakeRole of Kir2.1 in human monocyte-derived foam cell maturation.Immune function in Amazonian horticulturalists.Changes in macrophage function modulated by the lipid environment.Inflammation-modulating cytokine profile and lipid interaction in HIV-related risk factors for cardiovascular diseases.mTOR enhances foam cell formation by suppressing the autophagy pathway.Liver X receptors, atherosclerosis and inflammation.
P2860
Q24297353-06DC474F-04AF-48E6-BFFA-20C657C82886Q26782277-FFE4F988-2B0D-46BC-A507-E6544B4E4FF3Q26800135-E9A09CB6-5B77-4177-966D-849B6E0DEE88Q26801787-2F358956-5455-45C4-B324-5DACB507DDA0Q26866225-7DBE296F-37D5-4D54-A78A-5D0D1148A5A4Q27021351-FF79F688-2D4C-482B-97C1-6B6304C14B79Q28067396-C4D79FB3-B5AE-4E29-AA47-796A0EB33EEFQ28069923-99C8ADC9-B1AD-4536-B28D-5078853C0901Q30541611-DE77CB08-2062-497D-9120-099DE3C2174AQ33623946-24B3E228-0BBF-4C38-A0D3-368E469ECAC3Q33767580-C2188E67-5D49-4A76-A222-4F7D24ED20D5Q33883204-BDEF580D-E4D7-4178-904C-E55F66CA66D1Q34071063-F16440C1-79BB-4004-84C7-D9DE4A409232Q34167096-2BCFD37C-CB42-49D4-9986-15D0CA859818Q34287053-22C7594B-46BD-43E5-965D-5DAFCF5FF343Q34400291-2AB7AA7F-5757-41EB-A989-6005412F9CD2Q34482501-D7851B90-938F-46CD-BB60-FD5CF9D17732Q34565266-BD7C6ED6-4164-4483-9514-66F0B26FDC62Q34780877-7C9D8674-405E-41CA-A940-8591796DD58BQ34823855-AECF5611-D665-429B-8A7E-20A0CC8F9B95Q35052649-48B4AB86-8FDF-451E-9009-7505082A2131Q35070231-E87F4EF9-834D-4960-B253-E4EFFE87E689Q35095407-4A057EC4-79F5-411C-B294-C1DE4D9E643FQ35099028-C989340E-D59A-46BF-BE50-7161F49CA1A4Q35557995-4B171497-7241-428D-9784-01C0FAA86EDDQ35573925-C47895C4-2627-4AB7-9EE0-3AE496208888Q35640438-55906F04-648E-4EBA-A411-C8A913D26C8AQ35703099-944B3D68-EB21-4FA3-B2F6-245071DE4967Q35738502-6CBF2C9D-40D8-4F62-AF68-7C82DAA315B5Q35948024-6D9567C3-24AA-4B49-B29C-F879C5783DE8Q36012491-F4C5857D-8E42-4EB5-AF0C-7DE7B494B312Q36064353-A7450557-1E4C-4C38-A630-2DB5BAF9805EQ36068816-1970D1DA-3F56-4463-B35B-BC74D897958FQ36149170-604EBB80-52CD-4BFE-ADA2-9E66D92AF616Q36595268-86B2EABD-FAE6-476A-B926-BC2A85F1B771Q37156722-91A116B3-2DE8-4092-9D90-8548952B1032Q37404095-CC72BFFA-74C1-4BEB-9A97-4D8A1326C125Q37420764-CD1F515F-144D-4B86-B7C5-DBF58F3AD80EQ37667610-A527199D-51FB-4F00-9515-B444E98387B7Q37993787-14FB2F8A-6DFA-40AC-87CD-FCDADF9448AE
P2860
Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cytokines, macrophage lipid me ...... ardiovascular disease therapy.
@ast
Cytokines, macrophage lipid me ...... ardiovascular disease therapy.
@en
type
label
Cytokines, macrophage lipid me ...... ardiovascular disease therapy.
@ast
Cytokines, macrophage lipid me ...... ardiovascular disease therapy.
@en
prefLabel
Cytokines, macrophage lipid me ...... ardiovascular disease therapy.
@ast
Cytokines, macrophage lipid me ...... ardiovascular disease therapy.
@en
P1476
Cytokines, macrophage lipid me ...... cardiovascular disease therapy
@en
P2093
Daryn R Michael
Tim G Ashlin
P304
P356
10.1016/J.PLIPRES.2011.04.002
P577
2011-05-13T00:00:00Z